• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

吡咯里西啶生物碱所致肝窦阻塞综合征的明确诊断。

Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.

机构信息

Department of Gastroenterology, Zhongshan Hospital Fudan University, Shanghai, China.

出版信息

J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.

DOI:10.1111/j.1751-2980.2011.00552.x
PMID:22188914
Abstract

OBJECTIVE

Hepatic sinusoidal obstruction syndrome (HSOS) induced by a Chinese medicinal herb Tusanqi is increasingly being reported in recent years. The aim of the study was to investigate the possibility of using blood pyrrole-protein adducts test as a confirmatory diagnostic method.

METHODS

Patients with HSOS according to international diagnostic criteria associated with Tusanqi from January 2006 to August 2010 in Zhongshan Hospital Fudan University were included and clinical features were collected. Pyrrole-protein adducts in blood sample were determined with ultra performance liquid chromatography-mass spectrometry (UPLC-MS) while pyrrolizidine alkaloids (PAs) in available herbal preparations were analyzed by high performance liquid chromatography-ultraviolet (HPLC-UV).

RESULTS

Five patients (age 41-72 years, median age 54 years, all women) were included. Ascites (5/5), jaundice (5/5) and hepatomegaly (4/5) were common manifestations. The imaging features were diffused, patchy hepatic enhancement, periportal edema and ascites. Pathology ascertained that blood flow was obstructive at the site of sinusoid. PAs (Seneionine and seneciphylline) were identified in all the three available herbal preparations ingested by the HSOS patients. Pyrrole-protein adducts were unequivocally found in all the five blood samples. Two patients recovered, two developed chronic illness and one died due to liver failure and hepatic encephalopathy.

CONCLUSIONS

The detection of blood pyrrole-protein adducts using a UPLC-MS approach is a specific, reliable, unambiguous and confirmatory test for HSOS induced by PA, and should be used together with the conventional HSOS clinical diagnostic criteria for the definitive diagnosis of PA-induced HSOS.

摘要

目的

近年来,越来越多的报道称中药土三七引起肝窦阻塞综合征(HSOS)。本研究旨在探讨血液吡咯蛋白加合物检测作为一种确认性诊断方法的可能性。

方法

纳入 2006 年 1 月至 2010 年 8 月在复旦大学中山医院按国际诊断标准诊断的与土三七相关的 HSOS 患者,并收集其临床特征。采用超高效液相色谱-质谱联用(UPLC-MS)法检测血样中的吡咯蛋白加合物,高效液相色谱-紫外(HPLC-UV)法分析可获得的草药制剂中的吡咯里西啶生物碱(PAs)。

结果

共纳入 5 例患者(年龄 41-72 岁,中位年龄 54 岁,均为女性)。腹水(5/5)、黄疸(5/5)和肝肿大(4/5)是常见表现。影像学特征为弥漫性、斑片状肝增强、门静脉周围水肿和腹水。病理学证实窦状隙血流阻塞。HSOS 患者服用的 3 种草药制剂中均检出 PAs(千里光宁和千里光菲灵)。5 份血样中均明确检测到吡咯蛋白加合物。2 例患者痊愈,2 例发展为慢性疾病,1 例因肝功能衰竭和肝性脑病死亡。

结论

采用 UPLC-MS 方法检测血液吡咯蛋白加合物是一种特异性、可靠、明确和可确认的 PA 引起的 HSOS 检测方法,应与传统的 HSOS 临床诊断标准一起用于 PA 引起的 HSOS 的明确诊断。

相似文献

1
Definitive diagnosis of hepatic sinusoidal obstruction syndrome induced by pyrrolizidine alkaloids.吡咯里西啶生物碱所致肝窦阻塞综合征的明确诊断。
J Dig Dis. 2012 Jan;13(1):33-9. doi: 10.1111/j.1751-2980.2011.00552.x.
2
Hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.与食用菊三七相关的肝窦阻塞综合征。
J Hepatol. 2011 Apr;54(4):666-73. doi: 10.1016/j.jhep.2010.07.031. Epub 2010 Sep 22.
3
Blood pyrrole-protein adducts as a diagnostic and prognostic index in pyrrolizidine alkaloid-hepatic sinusoidal obstruction syndrome.血中吡咯-蛋白质加合物作为吡咯里西啶生物碱致肝窦阻塞综合征的诊断和预后指标
Drug Des Devel Ther. 2015 Aug 25;9:4861-8. doi: 10.2147/DDDT.S87858. eCollection 2015.
4
Tusanqi and hepatic sinusoidal obstruction syndrome.土三七和肝窦阻塞综合征。
J Dig Dis. 2014 Mar;15(3):105-7. doi: 10.1111/1751-2980.12112.
5
Diagnostic performance of Contrast-enhanced CT in Pyrrolizidine Alkaloids-induced Hepatic Sinusoidal Obstructive Syndrome.吡咯里西啶生物碱诱导的肝窦阻塞综合征的 CT 增强扫描诊断性能。
Sci Rep. 2016 Nov 29;6:37998. doi: 10.1038/srep37998.
6
Clinical characteristics, CT signs, and pathological findings of Pyrrolizidine alkaloids-induced sinusoidal obstructive syndrome: a retrospective study.吡咯里西啶生物碱诱导的肝窦阻塞综合征的临床特征、CT表现及病理结果:一项回顾性研究
BMC Gastroenterol. 2020 Feb 4;20(1):30. doi: 10.1186/s12876-020-1180-0.
7
Pyrrolizidine alkaloids-induced hepatic sinusoidal obstruction syndrome: Pathogenesis, clinical manifestations, diagnosis, treatment, and outcomes.吡咯里西啶生物碱诱导的肝窦阻塞综合征:发病机制、临床表现、诊断、治疗和结局。
World J Gastroenterol. 2019 Jul 28;25(28):3753-3763. doi: 10.3748/wjg.v25.i28.3753.
8
First evidence of pyrrolizidine alkaloid N-oxide-induced hepatic sinusoidal obstruction syndrome in humans.首例吡咯里西啶生物碱 N-氧化物诱导的肝窦阻塞综合征的人类证据。
Arch Toxicol. 2017 Dec;91(12):3913-3925. doi: 10.1007/s00204-017-2013-y. Epub 2017 Jun 15.
9
The long persistence of pyrrolizidine alkaloid-derived pyrrole-protein adducts in vivo: Kinetic study following multiple exposures of a pyrrolizidine alkaloid containing extract of Gynura japonica.体内吡咯里西啶生物碱衍生的吡咯蛋白加合物的长期持久性:含有菊三七提取物的吡咯里西啶生物碱多次暴露后的动力学研究。
Toxicol Lett. 2020 May 1;323:41-47. doi: 10.1016/j.toxlet.2020.01.021. Epub 2020 Jan 23.
10
Gadoxetic Acid-Enhanced Hepatobiliary-Phase Magnetic Resonance Imaging for Pyrrolizidine Alkaloid-Induced Hepatic Sinusoidal Obstruction Syndrome and Association with Liver Function.吡咯里西啶生物碱诱导的肝窦阻塞综合征的钆塞酸增强肝胆期磁共振成像及与肝功能的关系。
Sci Rep. 2019 Feb 4;9(1):1231. doi: 10.1038/s41598-018-37775-1.

引用本文的文献

1
Computed tomography manifestations of drug-induced liver injury according to type and severity of injury.药物性肝损伤根据损伤类型和严重程度的计算机断层扫描表现
Quant Imaging Med Surg. 2025 Sep 1;15(9):8553-8566. doi: 10.21037/qims-24-2110. Epub 2025 Aug 11.
2
Gynura segetum induces hepatic sinusoidal obstruction syndrome in a child: A case report.《菊三七致儿童肝窦阻塞综合征 1 例报告》。
Medicine (Baltimore). 2024 Mar 15;103(11):e37341. doi: 10.1097/MD.0000000000037341.
3
Clinicopathological characteristics and diagnosis of hepatic sinusoidal obstruction syndrome caused by Tusanqi - Case report and literature review.
土三七致肝窦阻塞综合征的临床病理特征及诊断——病例报告并文献复习
Open Med (Wars). 2023 Jun 12;18(1):20230737. doi: 10.1515/med-2023-0737. eCollection 2023.
4
Physiologically based kinetic modeling of senecionine N-oxide in rats as a new approach methodology to define the effects of dose and endpoint used on relative potency values of pyrrolizidine alkaloid N-oxides.基于生理学的千里光碱 N-氧化物在大鼠体内的动力学建模:一种用于确定剂量和终点对吡咯里西啶生物碱 N-氧化物相对效价影响的新方法学。
Front Pharmacol. 2023 Mar 2;14:1125146. doi: 10.3389/fphar.2023.1125146. eCollection 2023.
5
New Insights into Herb-Induced Liver Injury.草药相关性肝损伤的新认识。
Antioxid Redox Signal. 2023 Jun;38(16-18):1138-1149. doi: 10.1089/ars.2022.0134. Epub 2023 Mar 2.
6
Liquorice Extract and 18β-Glycyrrhetinic Acid Protect Against Experimental Pyrrolizidine Alkaloid-Induced Hepatotoxicity in Rats Through Inhibiting Cytochrome P450-Mediated Metabolic Activation.甘草提取物和18β-甘草次酸通过抑制细胞色素P450介导的代谢活化来预防实验性吡咯里西啶生物碱诱导的大鼠肝毒性。
Front Pharmacol. 2022 Mar 16;13:850859. doi: 10.3389/fphar.2022.850859. eCollection 2022.
7
Pharmacotherapies for Drug-Induced Liver Injury: A Current Literature Review.药物性肝损伤的药物治疗:当前文献综述
Front Pharmacol. 2022 Jan 5;12:806249. doi: 10.3389/fphar.2021.806249. eCollection 2021.
8
Metabolic Toxification of 1,2-Unsaturated Pyrrolizidine Alkaloids Causes Human Hepatic Sinusoidal Obstruction Syndrome: The Update.1,2-不饱和吡咯里西啶生物碱的代谢解毒导致人类肝窦阻塞综合征:最新进展。
Int J Mol Sci. 2021 Sep 27;22(19):10419. doi: 10.3390/ijms221910419.
9
Herb-induced liver injury (HILI) with 12,068 worldwide cases published with causality assessments by Roussel Uclaf Causality Assessment Method (RUCAM): an overview.草药性肝损伤(HILI):全球12068例病例经鲁塞尔·优克福因果关系评估方法(RUCAM)进行因果关系评估后的概述。
Transl Gastroenterol Hepatol. 2021 Jul 25;6:51. doi: 10.21037/tgh-20-149. eCollection 2021.
10
Developing urinary pyrrole-amino acid adducts as non-invasive biomarkers for identifying pyrrolizidine alkaloids-induced liver injury in human.开发尿吡咯烷酸-氨基酸加合物作为非侵入性生物标志物,用于鉴定吡咯里西啶生物碱诱导的肝损伤。
Arch Toxicol. 2021 Oct;95(10):3191-3204. doi: 10.1007/s00204-021-03129-6. Epub 2021 Aug 14.